AngioDynamics, Inc. v. Biolitec AG

780 F.3d 420, 91 Fed. R. Serv. 3d 12, 2015 U.S. App. LEXIS 3801, 2015 WL 1045334
Court of Appeals for the First Circuit·Decided March 11, 2015·No. 13-1626, 13-2179·Published·Cited by 31 cases

Opinion

STAHL, Circuit Judge.

This is a companion case to AngioDynamics v. Biolitec AG, No. 14-1603. In this appeal, Defendants argue that the district court exceeded the bounds of its authority when it issued civil contempt sanctions after Defendants violated the court’s preliminary injunction order. Defendants also aver that the district court should have vacated the underlying preliminary injunction. We affirm.

I. Facts & Background

This court previously set out the basic factual contours of this case in AngioDynamics, Inc. v. Biolitec AG, 711 F.3d 248 (1st Cir.2013) (per curiam). Plaintiff AngioDynamics, Inc. (“ADI”) obtained a $23 million judgment in New York against defendant Biolitec, Inc. (“BI”), a New Jersey corporation with its principal place of business in Massachusetts, based on an indemnification clause in the supply and distribution agreement governing BI’s sale of medical equipment to ADI. Plaintiff sought to secure payment on that judgment by bringing suit in the District of Massachusetts against BI’s President and CEO, Wolfgang Neuberger, and its corporate parents, Biomed Technology Holdings (“Biomed”) and Biolitec AG (“BAG”) (collectively, “Defendants”), 1 alleging that Defendants had looted BI of over $18 million' in assets in order to render it judgment-proof.

We will recount only the portions of the procedural background of this case pertinent to the issues raised in this appeal. In August 2012, ADI learned that BAG planned to merge with an Austrian subsidiary. Since American judgments are unenforceable in Austria, the merger would place BAG’s assets out of ADI’s reach. The district court issued a temporary restraining order — later converted into a preliminary injunction — barring the merger. Defendants unsuccessfully filed a motion to vacate the injunction in the district court, then appealed. In March 2013, while that appeal was still pending, Defendants effected the merger anyway, moving BAG’S corporate domicile from Germany to Austria. This court affirmed the preliminary injunction on April 1, 2013, the same day as that panel heard oral argument. AngioDynamics, 711 F.3d at 252.

ADI filed an emergency motion for contempt shortly after learning that BAG had merged with its Austrian affiliate. On April 11, 2013, the district court issued a twenty-page contempt decision authorizing coercive fines against Defendants and a warrant for Neuberger’s arrest. AngioDynamics, Inc. v. Biolitec AG, 946 F.Supp.2d 205, 215 (D.Mass.2013). The monthly fines escalate in amount each month that the merger remains in place. Id. at 216. The district court’s contempt order made clear that it would lift the fines and arrest warrant once Defendants undo *424 the merger and restore the status quo ante. Id. at 215. Four months later, Defendants filed another round of motions to revoke the contempt order and vacate the underlying injunction; the district court denied the motions yet .again. AngioDynamics, Inc. v. Biolitec AG, 974 F.Supp.2d 1, 5-11 (D.Mass.2013). These appeals followed.

II. Analysis

A. Denial of Rule 60(b) Motion to Vacate Preliminary Injunction

We begin with Defendants’ challenge to the district court’s denial of their motion to vacate the preliminary injunction pursuant to Federal Rules of Civil Procedure 60(b)(4) and 60(b)(6). 2 Defendants presented two sets of declarations in support of their motion to refute the district court’s finding at the preliminary injunction stage that relocating BAG to Austria would make it more difficult or impossible for ADI to enforce its judgment against the company.

Rule 60(b)(4) permits a party to move for relief from an order on grounds that it is void. We review the denial of a Rule 60(b)(4) motion de novo, as the validity of a judgment is not a discretionary question. Fafel v. Dipaola, 399 F.3d 403, 409-10 (1st Cir.2005). Rule 60(b)(6), by contrast, is a catch-all. provision warranting excusal from an order or judgment for “any other reason that justifies relief 1 ’; the denial of such a request is reviewed for abuse of discretion. Ungar v. Palestine Liberation Org., 599 F.3d 79, 83 (1st Cir.2010).

Under either standard, Defendants cannot use their Rule 60(b) motion to col *425 laterally attack the preliminary injunction, which this court already has considered and affirmed. AngioDynamics, 711 F.3d at 252. A Rule 60(b) motion “must satisfy a special set of criteria; it is not enough merely to cast doubt on the soundness of the underlying judgment.” Nansamba v. N. Shore Med. Ctr., 727 F.3d 33, 37 (1st Cir.2013). The moving party must demonstrate in a timely motion that “ ‘exceptional circumstances exist, favoring extraordinary relief; that if the judgment is set aside, he has the right stuff to mount a potentially meritorious claim or defense; and that no unfair prejudice will accrue to the opposing parties should the motion be granted.’ ” Id. (quoting Fisher v. Kadant, Inc., 589 F.3d 505, 512 (1st Cir.2009)).

Defendants’ motion does little to even cast doubt on the underlying injunction. First, they offer two declarations from one of their experts on German law — an expert who previously offered multiple declarations in opposition to ADI’s original preliminary injunction motion — to refute the district court’s finding that ADI cannot enforce its judgment in Austria, but might be able to enforce it in Germany. Essentially, Defendants assert that the downstream merger with the Austrian subsidiary will have no practical impact on ADI’s ability to collect, and thus ADI will suffer no harm from Defendants’ violation' of the court’s preliminary injunction. The expert opined that ADI would face the same burden enforcing its judgment in Germany as in Austria, virtually the same opinion Defendants’ experts had offered and the district court and this court have already rejected.

Second, Defendants offer Neuberger’s own declaration in support of their assertion that a German court will not recognize the district court’s jurisdiction over BAG — and thus will not enforce ADI’s judgment — because ADI is unable to present affirmative evidence that BAG’s stock certificates were located in .the United States at the time ADI commenced this action.

Free access — add to your briefcase to read the full text and ask questions with AI

AngioDynamics, Inc. v. Biolitec AG, 780 F.3d 420, 91 Fed. R. Serv. 3d 12, 2015 U.S. App. LEXIS 3801, 2015 WL 1045334 (1st Cir. 2015).

780 F.3d 420 (AngioDynamics, Inc. v. Biolitec AG) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related